2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Pericardial Effusion: new trials by email Literature Review of Pericardial Effusion trials Research Report on Pericardial Effusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer Bevacizumab - Non-small Cell Lung Cancer, Malignant Pleural Effusion | Phase 2 | Completed | Haihong Yang, MD, Pricipal investigator | 22 | 2014-01-01 | 2019-03-29 |
| Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer Alimta - Lung Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 64 | 2005-09-01 | 2017-02-13 |
Carcinoma, Non-Small-Cell Lung (2) · Pleural Effusion, Malignant (2) · Lung Neoplasms (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pleural Diseases (2) · Pleural Effusion (2) · Pleural Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Lung Neoplasms (1)
Bevacizumab (1) · Pemetrexed (1)
Haihong Yang, MD, Pricipal investigator (1) · M.D. Anderson Cancer Center (1)
China (1) · United States (1)
Haihong Yang, MD (1) · Ralph Zinner, MD (1)